Albumin and fibrinogen synthesis and insulin effect in type 2 diabetic patients with normoalbuminuria

Diabetes Care

Volumn 29, Issue 2, 2006, Pages 323-328

  Tessari, Paolo ^a   Kiwanuka, Edward ^a   Millioni, Renato ^a   Vettore, Monica ^a   Puricelli, Lucia ^a   Zanetti, Michela ^a   Gucciardi, Antonella ^b   Tosolini, Marina ^a   Cogo, Paola ^b   Carnielli, Virgilio ^c   Tiengo, Antonio ^a   Barazzoni, Rocco ^a  

^a UNIVERSITY HOSPITAL OF PADOVA   (Italy)

^b UNIVERSITY OF PADOVA   (Italy)

^c UNIVERSITÀ POLITECNICA DELLE MARCHE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; FIBRINOGEN; GLUCOSE; INSULIN; ISOTOPE; LEUCINE; ANTIDIABETIC AGENT; GLUCAGON; SERUM ALBUMIN;

ADULT; ALBUMIN BLOOD LEVEL; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FIBRINOGEN BLOOD LEVEL; FIBRINOGEN DEFECT; FRACTIONATION; GLUCOSE BLOOD LEVEL; GLUCOSE CLAMP TECHNIQUE; HUMAN; HYPERINSULINEMIA; INSULIN SYNTHESIS; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; BIOSYNTHESIS; BLOOD; CASE CONTROL STUDY; DRUG EFFECT; HYPERTENSION; METABOLISM; PATHOPHYSIOLOGY;

ADULT; CASE-CONTROL STUDIES; DIABETES MELLITUS, TYPE 2; FIBRINOGEN; GLUCAGON; HUMANS; HYPERTENSION; HYPOGLYCEMIC AGENTS; INSULIN; LEUCINE; MALE; SERUM ALBUMIN;

EID: 33646351768     PISSN: 01495992     EISSN: 01495992     Source Type: Journal    
DOI: 10.2337/diacare.29.02.06.dc05-0226     Document Type: Article

References (29)

1. Fuhrman MP, Charney P, Mueller CM: Hepatic proteins and nutrition assessment. J Am Diet Assoc 104:1258-1264, 2004
2. Doweiko JP, Nompleggi DJ: Role of albumin in human physiology and pathophysiology. J Parent Ent Nutr 15:207-211, 1991
3. De Feo P, Gan Gaisano M, HaymondMW: Differential effects of insulin deficiency on albumin and fibrinogen synthesis in humans. J Clin Invest 88:833-840, 1991
4. Ganda OP, Arkin CF: Hyperfibrinogenemia: an important risk factor for vascular complications in diabetes. Diabetes Care 15:1245-1250, 1992
5. Barazzoni R, Zanetti M, Davanzo G, Kiwanuka E, Carraro P, Tiengo A, Tessari P: Increased fibrinogen production in type 2 diabetic patients without detectable vascular complications: correlation with plasma glucagon concentrations. J Clin Endocrinol Metab 85:3121-3125, 2000
6. Barazzoni R, Kiwanuka E, Zanetti M, Cristini M, Vettore M, Tessari P: Insulin acutely increases fibrinogen production in type 2 diabetic but not in non-diabetic people. Diabetes 52:1851-1856, 2003
7. Zanetti M, Barazzoni R, Garibotto G, Davanzo G, Gabelli C, Kiwanuka E, Piccoli E, Tosolini M, Tessari P: Plasma protein synthesis in patients with low grade nephrotic proteinuria. Am J Physiol 280:E591-E597, 2001
8. Haller M, Akbulut C, Brechtelsbauer H, Fett W, Briegel J, Finsterer U, Peter K: Determination of plasma volume with indocyanine green in man. Life Sci 53:1597-1604, 1993
9. Hoffmann JJML, Verhappen MAL: Automated nephelometry of fibrinogen: analytical performance and observations during thrombotic therapy. Clin Chem 34:2135-2140, 1998
10. Miles DW, Mogensen CE, Gundersen HJ: Radioimmunoassay for urinary albumin using a single antibody. Scand J Clin Lab Invest 26:5-11, 1970
11. Horber FF, Kahl J, Lecavalier L, Krom B, Haymond MW: Determination of leucine and alpha-ketoisocaproic acid concentrations and specific activity in plasma and of leucine specific activity in proteins using high performance liquid chromatography. J Chromatog 495:81-94, 1988
12. Schwenk WF, Berg PJ, Beaufrere B, Miles JM, Haymond MW: Use of t-butyl-dimethylsilylation in the GC/MS analysis of physiologic compounds found in plasma using electron impact ionization. Anal Biochem 141:101-109, 1984
13. Wolfe RR: Radioactive and Stable Isotope Tracers in Biomedicine: Principles and Practice of Kinetics Analysis. New York, Wiley-Liss, 1992
14. Ahlman B, Charlton M, Fu A, Berg C, O'Brien P, Nair KS: Insulin's effect on synthesis rates of liver proteins: a swine model comparing various precursors of protein synthesis. Diabetes 50:947-954, 2001
15. Schwenk WF, Beaufrere B, Haymond MW: Use of reciprocal pool specific activities to model leucine metabolism in man. Am J Physiol 249:E646-E650, 1985
16. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC: Homeostatic model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28:412-419, 1985
17. Volpi E, Lucidi P, Cruciali G, Monacchia F, Reboldi G, Brunetti P, Bolli GB, De Feo P: Contribution of amino acids and insulin to protein anabolism during meal absorption. Diabetes 45:1245-1252, 1996
18. Kimball SR, Horetsky RL, Jefferson LS: Hormonal regulation of albumin gene expression in primary cultures of rat hepatocytes. Am J Physiol 268:E6-E14, 1995
19. Henry I, Uzan G, Weil D, Nicolas H, Kaplan JC, Marguerie C, Kahn A, Junien C: The genes coding for A alpha-, B beta-, and gamma-chains of fibrinogen map to 4q2. Am J Hum Genet 36:760-768, 1984
20. Fonad FM, Abd-Fattah M, Scherer R, Ruthenstroth-Bauer G: Effects of glucocorticoids, insulin and a growth promoting tripeptide on the biosynthesis of plasma proteins in serum-free hepatocyte cultures. Z Naturforsh 36:350-352, 1981
21. Tessari P, Iori E, Vettore M, Zanetti M, Kiwanuka E, Davanzo G, Barazzoni R: Evidence for acute stimulation of fibrinogen production by glucagon in humans. Diabetes 48:1368-1371, 1997
22. Moshage HJ, Princen HM, van Pelt J, Roelofs HM, Nieuwenhuizen W, Yap SH: Differential effects of endotoxin and fibrinogen degradation products (FDPS) on liver synthesis of fibrinogen and albumin: evidence for the involvement of a novel monokine in the stimulation of fibrinogen synthesis induced by FDPS. Int J Biochem 22:1393-1400, 1990
23. Moshage HJ, Kleter BE, van Pelt JF, Roelofs HM, Kleuskens JA, Yap SH: Fibrinogen and albumin synthesis are regulated at the transcriptional level during the acute phase response. Biochim Biophys Acta 950:450-454, 1988
24. Afolabi PR, Jahoor F, Gibson NR, Jackson A: Response of hepatic proteins to the lowering of habitual dietary protein to the recommended safe level of intake. Am J Physiol 287:E327-E330, 2004
25. Grieninger G, Plant PW, Liang TJ, Kalb RG, Amrani D, Mosesson MW, Hertzberg KM, Pindyck J: Hormonal regulation of fibrinogen synthesis in cultured hepatocytes. Ann N Y Acad Sci 27:408:469-489, 1983
26. Folsom AR, Wu AR, Davis CE, Conlan MG, Sorlie PD, Szklo M: Population correlates of plasma fibrinogen and factor VII, putative cardiovascular risk factors. Atherosclerosis 91:191-205, 1991
27. Balagopal P, Sweeten S, Mauras N: Increased synthesis rate of fibrinogen as a basis for its elevated plasma levels in obese female adolescents. Am J Physiol 282:E899-E904, 2002
28. Gougeon R, Pencharz PB, Marliss EB: Effect of NIDDM on the kinetics of whole-body protein metabolism. Diabetes 43:318-328, 1994
29. Fogari R, Zoppi A, Lazzari P, Preti P, Mugellini A, Corradi L, Lunardi P: ACE inhibition but not angiotensin II antagonism reduces plasma fibrinogen and insulin resistance in overweight hypertensive patients. J Cardiovasc Pharmacol 32:616-620, 1998